NMTC

NeuroOne Medical Technologies Corporation

NMTC · CIK 1500198 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$9M
20172025
Net Income−$4M
20172025
Operating CF−$3M
20172025
Free Cash Flow−$3M
20172025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B———
Cost of Revenue$0.0B$0.0B$0.0B$0.0B$0.0B———
Gross Profit$0.0B$0.0B$0.0B$-0.0B$-0.0B———
R&D Expense$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B—
SG&A Expense$0.0B$0.0B$0.0B$0.0B————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B—
Net Income$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-0.09$-0.46$-0.65$-0.63————
EPS (Diluted)$-0.09$-0.46$-0.65$-0.63————

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕
Total Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Total Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$-0.0B$-0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2017↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B—
Investing Cash Flow$-0.0B$-0.0B$0.0B$-0.0B$-0.0B$-0.0B$-0.0B—
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B—
Financing Cash Flow$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B—
← Companies